vaccin
repres
effect
prophylact
strategi
arsen
control
spread
infecti
diseas
increas
human
life
expect
exampl
erad
smallpox
massiv
reduct
infecti
diseas
polio
measl
diphtheria
repres
major
vaccin
victori
last
centuri
despit
import
success
achiev
vaccin
ongo
effort
continu
toward
develop
new
protect
vaccin
name
number
challeng
still
remain
context
vaccin
specif
mani
commerci
avail
vaccin
fail
elicit
longlast
immun
respons
insuffici
trigger
cellmedi
mucos
immun
moreov
mani
vaccin
remain
depend
cold
chain
mainten
antigen
potenc
final
vaccin
complianc
remain
issu
societi
often
vaccin
compos
attenu
inactiv
pathogen
capabl
elicit
protect
immun
respons
avoid
complic
associ
infect
recent
year
thank
advanc
biotechnolog
improv
product
recombin
protein
vaccin
strategi
develop
approv
human
use
mani
vaccin
produc
use
recombin
technolog
current
develop
evalu
clinic
trial
exampl
hbv
hpv
serogroup
b
meningococc
vaccin
current
use
compos
subunit
focu
immun
respons
toward
specif
compon
pathogen
moreov
improv
vaccin
elicit
cellmedi
mucos
immun
new
dnabas
viral
vectorbas
novel
vaccin
deliveri
platform
along
usag
adjuv
chemotact
agent
develop
regard
n
cotugno
et
al
describ
use
omic
techniqu
identifi
specif
genom
profil
defin
vaccin
system
might
use
nonrespond
individu
e
criscuolo
et
al
review
recent
advanc
edibl
vaccin
system
intraderm
vaccin
deliveri
new
vaccin
strategi
repres
signific
advanc
vaccin
stabil
consid
fact
requir
cold
chain
e
n
gari
kutzler
discuss
use
chemokin
adjuv
induc
mucos
immun
koutsoni
et
al
describ
new
adjuv
leishmania
eukaryot
initi
factor
consid
natur
adjuv
antigen
highlight
immunomodulatori
properti
vitro
vivo
addit
challeng
toward
reduc
transmiss
infecti
diseas
remain
control
spread
pathogen
microorgan
anim
reservoir
anoth
import
step
toward
complet
erad
regard
vaccin
domest
poultri
livestock
import
tool
maintain
anim
health
also
essenti
reduc
spread
zoonot
pathogen
nipah
viru
infect
sever
acut
respiratori
syndrom
highli
pathogen
avian
influenza
hpai
exampl
infecti
diseas
origin
transmiss
wild
anim
reservoir
livestock
human
develop
highli
effect
vaccin
livestock
anim
therefor
essenti
block
transmiss
zoonot
pathogen
human
experiment
challeng
transmiss
model
v
palya
et
al
show
vectorbas
vaccin
effici
protect
commerci
broiler
layer
pullet
hpai
viru
infect
especi
underdevelop
countri
afford
new
gener
vaccin
critic
import
reduc
diseas
transmiss
human
livestock
speci
necessari
step
direct
burakova
et
al
describ
develop
costeffect
veterinari
vaccin
formul
open
special
issu
recent
advanc
design
formul
deliveri
vaccin
infecti
diseas
cover
three
review
articl
nine
research
paper
guest
editor
open
special
issu
hope
reader
find
content
interest
work
inspir
continu
effort
toward
develop
implement
improv
vaccin
